The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine

Annals of Clinical Biochemistry
Scott Blackwell

Abstract

Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase and an important cause of endothelial dysfunction. Its increased plasma concentration is associated with a variety of traditional cardiovascular risk factors, and may mediate their effects on the vascular endothelium. ADMA is also an independent predictor of cardiovascular events and mortality, and predicts outcomes in critically ill patients in the intensive care unit. This work has provided insights into the role of ADMA as an endogenous regulator of nitric oxide synthesis. At present there is no specific therapy to modify ADMA concentration, but increasing interest and work on protein arginine methyltransferases and dimethylarginine dimethylaminohydrolase, which synthesize and metabolize ADMA, respectively, might provide novel therapeutic targets.

Citations

May 2, 2014·Seminars in Nephrology·Joachim JankowskiAlessandra F Perna
Jun 22, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ines ReicheStefanie M Bode-Böger
Jan 5, 2011·International Journal of Nephrology·Akihiko SaitoHiroyoshi Sato
Oct 5, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sopanahalli N MamathaRita Christopher
Oct 22, 2011·Alcoholism, Clinical and Experimental Research·Cristiana Di GennaroAlberto Montanari
Dec 24, 2010·European Journal of Clinical Investigation·Scott BlackwellDinesh Talwar
Sep 6, 2011·The American Journal of Cardiology·Maria Cristina D ThomazellaFrancisco R M Laurindo
Feb 15, 2014·Clinical Biochemistry·Spyridon DeftereosGeorgios Giannopoulos
Dec 9, 2016·European Journal of Clinical Investigation·Rawia A GhashutDinesh Talwar
Mar 21, 2012·The Journal of International Medical Research·M Yusuf AlsagaffY Tomino
Apr 15, 2016·Journal of Child Neurology·Serdar Tasdemir, Oguzhan Oz
Apr 26, 2018·Acta Physiologica·M CarlströmE Weitzberg
Aug 20, 2014·Journal of the American Heart Association·Aaron L SverdlovJohn D Horowitz
Sep 7, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·M Odette GoreRainer H Böger
Mar 15, 2019·Acta Anaesthesiologica Scandinavica·Karoline Myglegård MortensenMorten Heiberg Bestle
Jan 18, 2018·PLoS Neglected Tropical Diseases·Sofía CarbajosaNúria Gironès
Sep 25, 2019·International Journal of Molecular Sciences·Antonino TuttolomondoAntonio Pinto
Oct 23, 2019·The Journal of Applied Laboratory Medicine·Tama ThéUNKNOWN with the Pediatric Emergency Medicine Collaborative Research Committee (PEM-CRC)
Aug 24, 2012·American Journal of Hypertension·Rafael Moreno-LunaPablo Stiefel
Nov 26, 2016·Neurochemical Research·Anna CzarneckaMagdalena Zielińska
Nov 28, 2013·Current Opinion in Clinical Nutrition and Metabolic Care·Saskia J H BrinkmannPaul A M van Leeuwen
Dec 10, 2016·The Journal of Nutrition·Sidney M Morris
Dec 18, 2018·Frontiers in Immunology·Mahin Abad Dar, Christoph Hölscher
Feb 9, 2019·Cardiovascular Diabetology·Damilola D AdingupuAnn-Cathrine Jönsson-Rylander
Jun 19, 2019·Physiological Reports·Jennifer K TrittmannLeif D Nelin
Jul 1, 2020·Terapevticheskiĭ arkhiv·V I PodzolkovD U Natkina
May 17, 2021·Journal of Cardiac Surgery·Tolga BaşAli Kutsal

❮ Previous
Next ❯

Methods Mentioned

BETA
reverse-phase chromatography
enzyme-linked immunosorbent assay
ELISA

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.